| Serial Number | 79386468 |
| Word Mark | CELEGAGE |
| Filing Date | Tuesday, October 17, 2023 |
| Status | 694 - WITHDRAWN BEFORE ISSUE |
| Status Date | Thursday, December 26, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 17, 2024 |
| Goods and Services | Laboratory apparatus and instruments for inputting, extracting, transmitting, processing and storing data, in particular scientific and medical data, namely, laboratory robots, data processors, electronic data loggers; scientific research and laboratory apparatus, namely, bio-chips for research or scientific purposes, pharmaceutical and scientific research equipment for use in mass spectrometers, electrodes for laboratory research; educational apparatus and simulators, namely, downloadable educational software featuring instruction in electronic clinicians training simulators; incubators for laboratory use; bioreactors for laboratory use; models for scientific experiments in laboratories, namely, downloadable computer simulation software for modeling the impact of drug combinations on health span markers; DNA chips; downloadable artificial intelligence software for data analysis and database management for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; downloadable artificial intelligence software for healthcare for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; downloadable artificial intelligence software for data analysis; downloadable software using artificial intelligence for machine learning for healthcare; downloadable health monitoring software for collecting, storing, computing, and analyzing health data; downloadable software relating to the medical field for controlling and managing patient medical information; downloadable software relating to the pharmaceutical field for drug discovery and development for data analysis; downloadable bioinformatics software for drug discovery and development, for controlling and managing patient medical information; electronic databases, namely, downloadable databases and electronic database recorded on computer media, for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data |
| Goods and Services | Pharmaceutical services, namely, pharmaceutical compounding, pharmaceutical advice; pharmaceutical consultation; pharmaceutical advisory services; provision of pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services; medical consultancy services; medical advisory services; medical evaluation services, namely, medical testing for fitness evaluation, medical evaluation of cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and conditions, conducting medical physical evaluations; medical diagnostic services; medical examination services; services for the provision of medical care information, namely, providing medical care information, providing medical care information via a website; medical services for the diagnosis of conditions of the human body; medical services for the treatment of conditions of the human body; performing diagnosis of diseases; medical care and analysis services relating to patient treatment; medical screening; drug screening for medical purposes; medical and health services relating to dna, genetics and genetic testing, namely, medical services, medical consultations, health care; genetic testing for medical purposes; medical tests, namely, medical testing services; provision of medical information in the field of prevention, screening, diagnosis and treatment of patients |
| Goods and Services | Pharmaceutical research services; pharmaceutical product evaluation; research and development in the field of microorganisms and cells; research of pharmaceuticals; testing of pharmaceuticals; research relating to pharmaceuticals; pharmaceutical products development; development of gene-based medicines; drug discovery services; conducting clinical trials for others for pharmaceutical products; scientific laboratory services; laboratory research services relating to pharmaceuticals; scientific risk assessment, namely, conducting scientific feasibility studies; consultancy in the field of pharmaceutical research; services for assessing the efficiency of pharmaceuticals, namely, testing of pharmaceuticals, pharmaceutical research and development; toxicity testing for scientific research purposes; toxicity analysis for scientific research purposes; information technology services for the pharmaceutical and healthcare industries, namely, information technology consultancy relating to installation, maintenance and repair of computer software; conducting early evaluations in the field of new pharmaceuticals, namely, testing of pharmaceuticals; providing information about pharmaceutical research, namely, the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals; chemical research and analysis services; medical and pharmacological research services; scientific services and research relating thereto, namely, scientific research, scientific laboratory services, scientific research consulting; scientific research for medical purposes; scientific research for medical purposes in the area of diseases; medical and scientific research, namely, conducting clinical trials for others; genetic research, namely, providing scientific research information in the field of genetics, providing medical research information in the field of genetics; genetic mapping for scientific purposes; dna screening for scientific research purposes; providing scientific information in the field of medical disorders and their treatment; Providing temporary use of non- downloadable artificial intelligence computer programs on data networks for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; platforms for artificial intelligence as software as a service (SaaS), namely, platform as a service (PAAS) featuring computer software platforms using artificial intelligence for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; software as a service (SaaS) services featuring computer software platforms using artificial intelligence for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; software as a service (SaaS) services featuring software for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; software as a service (SaaS) services featuring artificial intelligence software for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; software as a service (SaaS) services featuring artificial intelligence software for healthcare for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; software as a service (SaaS) services featuring artificial intelligence software for data analysis; software as a service (SaaS) services featuring software using artificial intelligence for machine learning for healthcare; software as a service (SaaS) services featuring health monitoring software for collecting, storing, computing, and analyzing health data; software as a service (SaaS) services featuring software relating to the medical field for controlling and managing patient medical information; software as a service (SaaS) services featuring bioinformatics software for drug discovery and development, for controlling and managing patient medical information; providing temporary use of non-downloadable software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; computer programming in the medical field; scientific computer programming services; artificial intelligence technology consultancy; research in the field of artificial intelligence |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 29, 2023 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 29, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 29, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Rejuvenate Biomed NV |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 98 - Unknown |
| Address | BE |
| Party Name | Rejuvenate Biomed NV |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | BE |
| Party Name | Rejuvenate Biomed NV |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | BE |
| Event Date | Event Description |
| Tuesday, January 2, 2024 | APPLICATION FILING RECEIPT MAILED |
| Thursday, March 28, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, March 29, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, December 28, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, December 29, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 27, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, April 17, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, May 9, 2024 | REFUSAL PROCESSED BY IB |
| Tuesday, April 16, 2024 | REFUSAL PROCESSED BY MPU |
| Wednesday, May 29, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 29, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 29, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, June 29, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Saturday, June 29, 2024 | FINAL REFUSAL E-MAILED |
| Saturday, June 29, 2024 | FINAL REFUSAL WRITTEN |
| Tuesday, August 13, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, August 13, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 13, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 13, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, August 28, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 17, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 17, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, November 8, 2024 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Thursday, December 26, 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Tuesday, August 13, 2024 | EXAMINER'S AMENDMENT ENTERED |